Rosen Quoted in Inside Health Policy About DeLaura, Bishop Relationship and FDA Spending Decisions
10 December 2020
Inside Health Policy
Partner David Rosen was quoted in the Inside Health Policy article, “DeLauro, Bishop Relationship Could Enhance FDA Approps,” about how incoming House Appropriations Committee Chair Rosa DeLauro (D-CT) could play a key role in FDA-related spending decisions due to her close dealings with Rep. Sanford Bishop (D-GA), who heads the FDA appropriations subcommittee that DeLauro has previously chaired.
Rosen told IHP that DeLauro’s interest in increasing access to medical products and engagement in the FDA regulatory process will make her a good committee chair.
(Subscription required.)
People
Related News
12 September 2024
In the News
Jeffrey Kopp on Workplace Discrimination Claims – 'Promptly investigate and take remedial action'
11 September 2024
In the News
Christopher Cain on Tech M&A Activity – 'VC firms need to have that release valve'
Foley & Lardner LLP partner Christopher Cain assessed M&A activity in the technology sector in the Mergers & Acquisitions article, "Tech M&A’s Uneven Comeback: Winners and Losers are Segment-Specific."
06 September 2024
In the News
Natasha Allen on California AI Legislation – 'California definitely wants to be on the forefront'
Foley & Lardner LLP partner Natasha Allen commented on recent California legislative action designed to regulate the development and deployment of artificial intelligence in the Law360 article, "Calif. Takes AI Reins With Looming Safety, Transparency Laws."